It is usually diagnosed in middle-aged males presenting with moderate hyperferritinemia (< 1500 ng/ml), normal transferrin saturation, and, in half of the cases, non-alcoholic fatty liver disease (NAFLD). This evidence concerns the gene TF and metabolic dysfunction-associated steatotic liver disease.